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Ovarian follicle culture: advances
and challenges for human and
nonhuman primates
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a Institute of Cell Biology, and b Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom;
c Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton; and
d Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon
The removal and cryostorage of ovarian cortical biopsies is now offered as a fertility preservation option for young women. The only
available option to restore fertility using this tissue is by transplantation, which may not be possible for all patients. The full potential of
this tissue to restore fertility could be achieved by the development of in vitro systems that support oocyte development from the most
immature stages to maturation. The techniques of in vitro growth (IVG) combined with in vitro maturation (IVM) are being developed
with human tissue, but comparing different systems has been difﬁcult because of the scarcity of tissue so nonhuman primates are being
used as model systems. There are many challenges to developing a complete culture system that would support human oocyte devel-
opment, and this review outlines the approaches being taken by several groups using tissue from
women and nonhuman primate models to support each of the stages of oocyte development.
(Fertil Steril 2013;99:1523–33. 2013 by American Society for Reproductive Medicine.)
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T he development of culture sys-tems with the aim of growingoocytes from the earliest stage
of follicle through to maturity for
in vitro fertilization (IVF) could have
a lasting impact on clinically assisted
reproduction, particularly for the
growing number of women who are
surviving cancer only to face infertil-
ity as a result of the gametotoxic ef-
fects of cancer therapies (1). Recent
success with ovarian tissue transplan-
tation (2–4) has expanded interest in
and efforts to cryopreserve and store
ovarian tissue for future fertility.
Ovarian tissue cryopreservation is the
only option available for young
patients without partners or who
cannot undergo ovarian stimulation
for oocyte/embryo cryopreservation
and for patients for whom the risk
for reintroduction of malignant cells
precludes transplantation. Thus, the
need for follicle culture systems that
can efﬁciently use all classes of
ovarian follicles, derived from
clinically cryopreserved ovarian
tissue, as sources of gametes would
maximize reproductive potential for
future fertility. However, complete
in vitro growth (IVG) from immature
primordial stages with subsequent
IVF of oocytes followed by embryo
transfer and production of live
offspring has, so far, been achieved
only in mice (5, 6). Several groups
have focused on culturing later
stages of follicle development from
rodents and have produced
developmentally competent oocytes
and viable offspring (7–11). The
success of these techniques has
encouraged the demanding challenge
of adapting them for humans and
other primates.
Although these techniques have
been used to study the regulation of fol-
licle development, the ultimate aim of
follicle culture is to increase the avail-
ability of developmentally competent
oocytes from what would be available
from conventional methods, and there
is still much to do before follicle culture
can be used as a strategy for obtaining
competent oocytes. In recent years
a great deal of progress has been
made in developing culture techniques
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for humans and nonhuman primates, and in this review we
describe the technologies and discuss the prospects as well
as the problems of applying them clinically.
FOLLICULAR DEVELOPMENT
Female reproductive function requires cyclic development
and maturation of ovarian follicles on a background of con-
tinuous activation from the pool of primordial follicles. Pri-
mordial follicles are formed before birth and represent
a population of germ cells from which recruitment for growth
occurs throughout the woman's reproductive life. Follicular
growth and development involves a series of complex and
precisely regulated events: 1) initiation of primordial follicle
growth and development to the preantral follicle stage; 2) for-
mation of antral follicles where expansion to the preovulatory
or graaﬁan follicle is associated with granulosa cell prolifer-
ation and antral ﬂuid accumulation within the basement
membrane; and 3) rupture of the graaﬁan follicle, releasing
a cumulus-oocyte complex at ovulation in response to the
midcycle LH surge (Fig. 1A).
As the oocyte grows within the follicle it is held in meiotic
arrest at the dictyate stage of prophase I, but during develop-
ment within the follicle it must acquire the ability to resume
meiosis (meiotic competence) and the ability to support fertil-
ization and embryonic development (developmental compe-
tence). Thus the oocyte depends on the local environment
within the follicle for subsequent function as a gamete, and
the formation and maintenance of connections facilitating
bidirectional communication between the oocyte and granu-
losa cells are key to oocyte development in all species.
The development of culture conditions for immature germ
cells (both eggs and sperm) is one of the greatest technical
challenges of reproductive technology. An understanding of
the physiologic requirements of the oocyte, granulosa, theca,
and perhaps even the stromal cells is needed. These require-
ments are complex and change during growth, so a major
consideration is the starting point of the culture system, i.e.,
which stage of follicle to start with. The majority of follicles
within the ovary in all young mammalian females are at the
primordial stage of development, and those follicles are con-
tinually being used during reproductive life (12). We do not
know if this pool represents a homogeneous population but
it is thought that at this stage follicles have not yet been ex-
posed to selection processes that lead to follicle degeneration
(13, 14). Although rodents are excellent models for pioneering
technologies, intermediate species are needed to test
feasibility for human applications. Follicles of some
domestic animals (cows, sheep, and goats) can resemble
those of humans regarding growth rates and size, but the
protracted length of folliculogenesis in vivo, estimated in
women to be 90 days from the entrance of a preantral
follicle into the growing pool to preovulatory follicles (15),
and the long length of the follicular phase of the
spontaneous menstrual cycle in nonhuman primates (2
weeks compared with a few days in domestic mammals)
more closely reﬂect that of women. Therefore, nonhuman
primates are emerging as an important translational model
to advance technologic developments in follicle culture.
DEVELOPMENT OF FOLLICLES IN VITRO
Several approaches have been taken to develop human fol-
licles in vitro with the use of fresh (16, 17) and thawed
cryopreserved (17, 18) human cortical tissue. It is now
clear that if we are to achieve complete development of
human oocytes, a dynamic multistep culture system is
required to support each of the transitional stages (16, 19–
21). The ﬁrst step is to support the initiation of primordial
follicle development and early growth, the second stage is
to optimize the growth of follicles from preantral to antral
stages, with the completion of oocyte growth being
achieved during the third stage. The focus should be
primarily on oocyte development, which may not require
the development of large follicular structures but rather
the maintenance of differentiated somatic cells in contact
with the developing oocyte. A multistep system for IVG
follicles has been proposed (22, 23) to produce competent
oocytes from human ovarian cortical tissue. The multistep
approach needs to support the changing requirements of
the developing oocyte and its surrounding somatic
(granulosa) cells with the main focus being on
maintaining oocyte–somatic cell interactions. Several
groups have worked on each of the steps required to
support human oocyte development in vitro: 1) activation
of primordial follicles through culturing ovarian cortex
(16, 17); 2) isolation and culture of growing preantral
follicles to achieve oocyte growth and development (16,
24–31); and 3) aspiration and maturation of oocyte-
cumulus complexes (32, 33). The aim of ongoing research
in this ﬁeld has been to combine each of these steps to
achieve complete development of human oocytes (16).
Progress in achieving this goal and the use of nonhuman
primate models will be reviewed.
Activation of Primordial Follicles
The majority of follicles within ovarian cortical tissue are qui-
escent primordial, so the ﬁrst consideration of an IVG system
should be to optimize initiation of primordial follicles in vitro
and support early follicle development. The factors regulating
follicle initiation and early growth are still not well deﬁned,
but the process requires a combination of inhibitory, stimula-
tory, and maintenance factors (34). Studies using knockout
mousemodels have demonstrated the importance of the phos-
phatidylinositol-30-kinase (PI3K)–Akt signaling pathway
within the oocyte in regulating follicle activation (35). The
phosphatase and tensin homologue deleted on chromosome
ten (PTEN) acts as a negative regulator of this pathway and
suppresses initiation of follicle development (35). The tran-
scription factor FOXO3a is a downstream effector of this
pathway and acts to inhibit follicle recruitment (36). However,
primordial follicles of fetal and juvenile macaque ovaries lack
FOXO3a expression, suggesting that alternative transcription
factors may mediate follicle activation in primates (37). Other
components of this pathway depend on themammalian target
of rapamycin complex 1 (mTORC1), a serine/threonine kinase
that regulates cell growth and proliferation in response to
growth factors and nutrients and regulates primordial follicle
activation (38). How these pathways regulate human follicle
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development is unclear, but culture models facilitate the study
of these processes. Using pharmacologic inhibitors of PTEN
in vitro, increased activation of presumably human primor-
dial follicles has been demonstrated after xenotransplanta-
tion of ovarian cortical strips into immunodeﬁcient mice
(39). A recent study using a human culture model has also
demonstrated that treatment with rapamycin (an inhibitor
of mTORC1) results in decreased activation of primordial fol-
licles as well as oocyte loss in growing follicles (40). Figure 1B
illustrates components of the PI3K pathway and their inﬂu-
ence on follicle activation.
One limitation of determining primordial follicle activa-
tion with the use of cultured human ovarian cortex includes
difﬁculty in assessing the follicular cohort within the starting
material. In human (41) and nonhuman primate (42) ovaries,
the distribution of follicles within the ovarian cortex is het-
erogeneous. It is important to note that follicular density
can vary more than two orders of magnitude in pieces of hu-
man cortical tissues from within the same ovary (41). Each
cortical piece has variation in number and stage distribution
of follicles, so it is difﬁcult to compare numbers of follicles
in a piece of control starting tissue with those in pieces
FIGURE 1
(A) Diagrammatic representation of follicle growth from the nonproliferating pool of primordial follicles. Primordial follicles are continuously
activated into the growing population, where they become primary follicles consisting of an oocyte arrested at the dictyate stage of prophase I
of meiosis (yellow) surrounded by granulosa cells (green). Primary follicles undergo oocyte growth and granulosa cell proliferation and
differentiation (purple), when they form an antral cavity. Antral follicles continue to grow, and granulosa cells differentiate into two
subpopulations of cells: 1) cumulus surrounding the oocyte (blue); and 2) mural lining the wall of the follicle (orange). Exact timings for this
developmental sequence in humans are not known; estimations suggest several months, but it is not known whether the growth proﬁle is
continuous or whether there are ‘‘resting’’ phases through follicle development. (B) Simpliﬁed version of the phosphatidylinositol-30-kinase
(PI3K) pathway. The factors initiating this process are largely unknown, but a body of evidence is emerging to show that the PI3K-Akt signaling
pathway is a major regulator of early follicle/oocyte development and that components of this pathway are involved in controlling the rate of
activation from the nongrowing population of follicles. The phosphatase PTEN converts phosphatidylinositol phosphate (PIP) 3 to PIP2, which
negatively regulates PI3K activity. Signaling mediated by PI3Ks converge at phosphatidylinositol phosphate dependent kinase-1 (PDK1).
Phosphatidylinositol-dependent kinase (PDK) 1 phosphorylates Akt and activates it. Akt can phosphorylate and inactivate tuberous sclerosis
complex 2 (TSC2, or tuberin), which leads to the activation of mammalian target of rapamycin complex 1 (mTORC1). mTORC1 can
phosphorylate (activate) S6 kinase 1 (S6K1). S6K1 subsequently phosphorylates and activates ribosomal protein S6 (rpS6), which enhances
protein translation that is needed for cell growth. mTORC1 can be inhibited pharmacologically with rapamycin and stimulated by leucine. The
manipulation of this pathway could have important clinical applications in the ﬁeld of fertility preservation. RPTK¼ receptor protein tyrosine kinase.
Telfer. Advances in ovarian follicle culture. Fertil Steril 2013.
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subjected to different treatments in vitro (43, 44). Recently,
a procedure using the vital dye neutral red was developed
for visualizing preantral follicles within ovine cortical
pieces and successfully applied to determining follicular
density in human cortical tissue (45, 46). Whether
primordial follicles can develop normally within the human
or nonhuman primate ovarian cortex during in vitro culture
after exposure to neutral red is not known, but if so, this
could prove to be a useful tool for identifying pieces of
cortex containing viable primordial follicles for experiments
on follicle activation, as well as for screening pieces of
tissue before ovarian transplantation.
Human primordial follicles can be activated to grow and
develop within mechanically loosened cortical pieces. Multi-
laminar preantral (secondary) stage follicles can be detected
in this system after 6 days of culture (16). This system differs
from those described in other studies (17, 26) because the
culture medium is serum free and no supporting matrix is
present. The vital step in this process lies in the preparation
of tissue which involves the removal of most of the
underlying stromal tissue and any growing follicles (Fig. 2).
When these small fragments of human ovarian cortex are
cultured, there is a signiﬁcant shift of follicles from the
quiescent to the growing pool over short culture periods of
6–10 days (16), an observation repeated in cows, where
extensive primordial activation has been reported within 2
days in vitro (22, 47, 48), indicating that activation results
from a release from intraovarian factors that act to inhibit
the initiation of follicle growth (49) (Fig. 2). It is clear that
tissue shape and stromal density are important factors that
contribute to the regulation of follicle growth initiation
in vitro, because solid cubes or strips (1 mm thick) of
human cortical tissue show less growth initiation (17) and
a high proportion of atretic follicles (50) compared with
cortex cultured as ﬂattened ‘‘sheets’’ where much of the
underlying stroma is removed (16). Likewise, relatively thin
pieces of macaque cortical tissue (0.5  1  1 mm) exhibit
atretic oocytes and follicles within contracted nonviable
tissue by 7 days of culture (Ting, personal communication).
The physical environment of the follicles within the cortical
tissue affects their response to stimulatory and inhibitory
factors and thus inﬂuences their ability to grow (49).
Primordial follicles isolated enzymatically from nonhu-
man primate (42) and human (50–52) ovarian tissue also
spontaneously grow in vitro. Remarkably, both human and
macaque primordial follicles initiate their growth at similar
sizes (30–40 mm) after isolation and grow to identical
diameters (50–58 mm) after 1 week in culture. In both
species, concomitant with the small increase in diameter,
granulosa cells surrounding the oocyte apparently
proliferate in a subset of these follicles and can be
morphologically identiﬁed after ﬁxation for hematoxylin
and eosin staining (42) or transmission electron microscopy
with toliduine blue staining (52), as depicted in Figure 3.
Human primordial follicles were reported to reach
secondary stages, based on the presence of more than one
layer of granulosa cells (52), despite their diameters being
much less than that typical for secondary follicles (150–225
mm) isolated from human (29) and macaque (27, 28) ovarian
cortex. The discrepancy may be attributed to the lack of
appreciable oocyte growth, as reported for macaque
primordial follicles (42), which is believed to occur in
primates concomitant with the rapid proliferation of
granulosa cells associated with the secondary stage (15).
Therefore, the multilayer ‘‘secondary’’ morphology may
actually represent an earlier developmental stage when the
oocyte is just initiating its growth. In these studies, groups
of primate primordial follicles were cultured within alginate
matrices, in which inhibitory interactions may be more
localized, although recent studies in mice suggest that
group culture of primordial follicles in alginate confers an
advantage to subsequent growth via paracrine mechanisms
(53). Until primate primordial follicle culture is extended to
intervals longer than 1 week, it is not known whether
currently reported culture conditions can support further
growth of both follicles and oocytes beyond ‘‘early’’
secondary stages.
Once follicle growth has been initiated within cortical tis-
sue, human follicles can develop tomultilaminar stages. Large
multilaminar follicles do not survive well within the cortical
environment, and it appears to be inhibitory to further growth,
resulting in a loss of follicle integrity and oocyte survival (16,
26). Therefore, to support further development, it appears that
multilaminar follicles need to be released from the cortical
stromal environment and cultured individually to limit the
effect of follicle interactions (16, 22) and/or oxidative
damage and nutrient diffusion into the tissue in vitro (Fig. 2).
Early Follicle Development In Vitro
Because of the limited amount of human tissue available for
clinical use and research, as well as declining follicle numbers
in specimens obtained from older versus younger patients,
optimizing the yield of good-quality follicles is important.
Isolation of preantral follicles from cortical tissue after culture
can be achieved by mechanical dissection, enzymatic isola-
tion, or a combination of both. Although enzymatic isolation
with the use of collagenase and DNase to remove preantral
follicles from stromal tissue results in more follicles than by
mechanical dissection (54, 55), it method can cause damage
that leads to poor survival of follicles. Growing follicles
need theca layers to retain their structure and to survive the
second stage of IVG, and collagenase treatment may
compromise those layers (56, 57). Some of this damage may
be avoided by using new puriﬁed enzyme preparations,
including liberase (42, 43, 52, 58). Careful mechanical
isolation with the use of ﬁne needles has the advantage of
preserving follicular integrity by maintaining the basal
lamina and theca layers of the follicle, but the yield is low
and the procedure slow because of the dense ﬁbrous cortical
tissue in human ovaries where follicles are embedded and
relatively inaccessible. In contrast, hundreds of secondary
follicles can be isolated from the similarly dense and ﬁbrous
ovarian cortex in a pair of rhesus macaque ovaries (27, 28),
and this is also age dependent as tissue from older primates
yields fewer follicles (27).
When culturing large mammalian follicles, the use of
V-shaped microwell plates has allowed maintenance of
1526 VOL. 99 NO. 6 / MAY 2013
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three-dimensional (3D) follicular architecture in vitro while
promoting growth and differentiation in cow (59–61) and
human (16) follicles, with antral formation occurring within
10 days. In addition to V-shaped microwell culture plates,
follicle encapsulation in alginate hydrogels has been used to
support secondary human (29), rhesus monkey (27, 28, 30),
and baboon (31) follicle growth in vitro. Alginate
encapsulation is thought to mimic the extracellular matrix
in vivo regarding its ability to facilitate nutrient, oxygen,
hormone, and growth factor exchange between the follicle
and the culture medium. Furthermore, its ﬂexibility can
accommodate cell proliferation, but its rigidity prevents
dissociation of the 3D follicular unit. The rigidity of the
alginate capsule affects follicle development, because
inhibition of growth and reduced steroidogenesis have been
reported in mouse follicles embedded in 1% alginate gels
(62), whereas fully grown human (29) and macaque (27, 28,
30) oocytes have been produced with the use of 0.5% and
0.25% gels, respectively. Indeed, a more rigid environment
of 2% alginate supported macaque primordial follicle
growth in vitro (42).
The progression of human follicles after isolation from
the cortex is remarkable. In the presence of FSH, enzymati-
cally isolated secondary human follicles can differentiate,
become steroidogenically active, and complete oocyte growth
in 30 days (29) (Fig. 4). Quiescent follicles activated to grow
within cultured fragments of cortex and mechanically iso-
lated as secondary follicles become steroidogenic and un-
dergo differentiation after a 10-day in vitro period with or
without activin (16). These observations conﬁrm that local
ovarian factors inhibit follicle development in vivo; however,
the question remains whether the growth rate observed
in vitro is accelerated or whether it represents growth without
the brakes that are required in vivo to regulate follicle devel-
opment within the context of the reproductive cycle. Like-
wise, recent advancements in understanding primate
folliculogenesis have been modeled in nonhuman primates,
where preantral follicle growth in vitro is initiated at the sec-
ondary stage. By this stage, early follicles have undergone ac-
tivation and selection through two steps of folliculogenesis
in vivo. Macaque secondary follicles (125–225 mm diameter)
isolated mechanically and encapsulated in alginate can sur-
vive (50% of the total isolated) and routinely achieve
growth to the small antral stage (1 mm diameter) in 4–5 weeks
under deﬁned culture conditions (27, 28) (Fig. 4). Follicle
survival and growth in vitro is a function of stage of the
menstrual cycle, ovarian age, oxygen concentration during
culture, and inclusion of fetuin in the medium (27, 28, 30).
FIGURE 2
Two-step culture system to obtain growing human follicles. (A) Outline of the preparation of human ovarian cortical biopsies to initiate
development of primordial follicles (step 1) and after 6 days in serum-free medium dissect out multilaminar growing follicles and grow these
individually (16). Photomicrograph of freshly prepared microcortex (B) before culture and (C) after 6 days of culture followed by (D) dissection
to isolate multilaminar follicles with theca cells attached. Isolated follicles can be cultured individually as outlined in A, and antral formation
occurs during a further 4-day culture period.
Telfer. Advances in ovarian follicle culture. Fertil Steril 2013.
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A semidegradable matrix containing ﬁbrin, alginate, and
Matrigel also facilitated baboon follicle expansion and
antrum formation in vitro (31) (Fig. 4).
Notably, surviving secondary follicles frommacaqueswere
heterogeneous regarding their growth rates in vitro when en-
capsulated in alginate as single follicles, a consistent feature
of secondary follicles in this system in every animal studied
to date. Three distinct cohorts were observed based on their di-
ameters at week 5 (27, 28). The cohort that does not
signiﬁcantly change in diameter (<250 mm) is termed ‘‘no-
grow’’ follicles. ‘‘Slow-grow’’ follicles represent the cohort
that doubles their diameters (250–500 mm). And the group
that increases their diameters at least threefold (>500 mm, in
some instances >1 mm) are designated ‘‘fast-grow’’ follicles.
All slow- and fast-grow follicles exhibit an antral cavity within
3–4 weeks of culture. Differences in follicle growth rate of sin-
gle human secondary follicles encapsulated in alginate were
less obvious, though it was noted that the majority of follicles
developed antral cavities, whereas others remained at the mul-
tilayer stage through 4 weeks of culture (29). Thus, the popula-
tion of secondary follicles in the primate ovary at early
follicular phase of the cycle is heterogeneous in the capacity
to grow in vitro. Growth rates may differ owing to follicle re-
sponse to FSH or other hormones (27, 28), or they may
respond to other local factors that regulate follicular growth.
The ability of human (29) and macaque (27, 28) follicles to
produce steroid hormones is also a function of follicle
growth. Only growing follicles synthesized increasing levels
of steroids beginning at antrum formation, with levels of E2,
androstenedione, and P greater in fast- than in slow-grow fol-
licles. Vascular endothelial growth factor (VEGF) production
also parallels steroidogenesis in growing follicles (27) and
may reﬂect a requirement for vascularization by the small an-
tral stage follicle to achieve further development in vivo with
additional substrates and release of hormones. In addition to
an angiogenic action, VEGF may protect antral follicles from
apoptosis and atresia. Interestingly, antim€ullerian hormone
(AMH) production by growing follicles exhibited a transient el-
evation atweeks 3–4 of culture; levelswere greater in fast- than
in slow-grow follicles (28). These data suggest that AMH may
be a biomarker for early preantral follicle growth, in addition
to being an important local regulator of folliculogenesis in pri-
mates. Direct actions of AMH on primate preantral follicles
await demonstration.
Xu et al. (63) recently developed a serum-free alginate-
encapsulated culture system for isolated primary follicles
from rhesus macaques. A number of unique features were
noted regarding secondary follicle culture, in that primary
follicles: 1) required 13 weeks to achieve the small antral stage
in vitro; 2) displayed only two growth patterns in vitro,
no-grow and fast-grow; 3) grew to secondary follicles within
4 weeks, at which time they produced AMH; and 4) did not
FIGURE 3
(Left) Representative histologic images of isolated rhesus macaque primordial follicles (A, B) after encapsulation in alginate at day 0, (C, D) cultured
for 6 days without encapsulation, or cultured for 6 days while encapsulated in (E, F) 0.5% or (G, H) 2% alginate. Scale bar ¼ 50 mm; asterisks
indicate oocytes (42). (Right) Morphology and histology of isolated human primordial follicles encapsulated in alginate (A) before in vitro
culture and (B) after 7 days in vitro, (C) a cryopreserved follicle after 7 days in vitro, and (D) a follicle isolated from cryopreserved-thawed
ovarian cortex after 7 days in culture. Images are at 40 magniﬁcation. Semithin sections of (E, 1,000) a cryopreserved isolated follicle and (F,
400) a follicle isolated from frozen-thawed ovarian cortex after 7 days of culture encapsulated in alginate (53). Left panel, reproduced from
Hornick et al. Hum Reprod 2012;27:1801-10 (42) by permission of the authors and Oxford University Press. Right panel, reproduced from
Vanacker et al. Fertil Steril 2013;99:1363-68.e2 (53) with permission from Elsevier.
Telfer. Advances in ovarian follicle culture. Fertil Steril 2013.
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produce steroids or VEGF until they began to rise with the ini-
tiation of antrum formation at 9 weeks in vitro. Thus, ma-
caque primary follicles encapsulated in alginate grow very
slowly and appear to be quiescent for a month regarding pro-
duction of somatic cell–derived hormones and factors until
granulosa cells proliferate with the beginning of secondary
follicle formation in vitro. For the ﬁrst time, a mature oocyte
was produced by an isolated macaque primary follicle in 3D
culture, but it developed only to a zygote after insemination
in vitro. Because primary follicles are more abundant within
the ovarian cortex than secondary follicles, they can provide
an additional cohort of growing preantral follicles for poten-
tial production of mature gametes in vitro.
A question arises as to just how large primate antral
follicles need to progress to produce a competent oocyte.
The typical diameter of a preovulatory follicle in macaques
is 5–6 mm, whereas it is much larger, 15–20 mm, in humans.
This poses a technical challenge for growing preantral folli-
cles to preovulatory diameters in vitro. Recent data provide
evidence that perhaps achieving the preovulatory size is not
necessary, and that preantral follicles can be grown to
much smaller antral sizes compatible with oocyte growth,
maturation, and competence. In macaques, small antral folli-
cles can be derived from the medulla of ovaries during early
follicular phase. This pool of follicles (0.5–2 mm diameter)
represents the cohort fromwhich the single dominant preovu-
latory follicle is selected. Developmental competence of ma-
caque oocytes to the blastocyst stage was possible when
oocytes matured in vitro were derived from 1–2-mm small
antral follicles (64). Deﬁnitive conﬁrmation of oocyte devel-
opmental competence from follicles smaller than preovula-
tory diameters was recently provided by Guzman et al. (65),
who reported live births from in vitro matured (IVM) human
oocytes retrieved from antral follicles%6 mm.
Table 1 summarizes the growth characteristics and oocyte
outcomes of growing primate follicles encapsulated in vary-
ing alginate matrices. Collectively, these studies represent
the most recent advances in 3D primate follicle culture and
demonstrate the principle that all classes of growing preantral
follicles can contribute to the reproductive potential of
women. Furthermore, these studies provide a glimpse into
the follicle selection process, in that cohorts of primordial, pri-
mary, and secondary follicles isolated from the ovarian cortex
are not homogeneous regarding their survival, growth rates,
and endocrine/paracrine functions in vitro. With the use of
a 3D supportivematrix, primary and secondary follicles main-
tained bidirectional communication between somatic cells
and the germ cell, creating an environment conducive to oo-
cyte growth and steroid production. Clearly, current culture
systems can support somatic cell functions of the preantral
follicular unit. The next crucial step is to demonstrate whether
the oocytes produced in these systems are capable of IVM and
to determine whether the growth pattern in vitro is deleterious
to oocyte function, epigenetic changes, and health.
Development of Fully Grown Oocytes
The ultimate aim of a follicle culture system is to obtain devel-
opmentally competent oocytes; therefore, these oocytes need
to be matured in vitro. IVM of oocytes already exists as a sep-
arate strategy and is used routinely in human assisted repro-
ductive technology processes with varying degrees of success
(66). As discussed earlier, achieving and sustaining oocyte
growth is the major objective of any complete in vitro devel-
opment system, because this is a size-speciﬁc indicator of the
oocyte's ability to resume meiosis (67, 68). The system must
also be capable of supporting nuclear maturation and
cytoplasmic differentiation of oocytes in vitro (69).
It is widely accepted that although 40%–80% of immature
human oocytes can successfully complete IMV and IVF giving
rise to live births, the rate of maturation of immature oocytes
is still well below that of oocytes harvested from stimulated
ovaries, indicating that the protocols are suboptimal or that
many of the harvested oocytes are intrinsically unable to
FIGURE 4
Representative images illustrating in vitro growth of nonhuman
primate and human preantral follicles enclosed in a three-
dimensional matrix to the small antral stage. The day of culture and
the follicular diameter is noted under each picture. Top panel
represents growth of a rhesus macaque secondary follicle (left) to
a small antral follicle (right); scale bars ¼ 250 mm; from M. Zelinski.
Middle panel depicts growth of a baboon multilayer follicle (left;
scale bar ¼ 100 mm) to a small antral follicle (right; scale bar ¼ 50
mm) (31). Bottom panel shows a human secondary follicle that
grew to a small antral follicle (scale bars ¼ 100 mm) (29). Middle
panel, republished with permission from Xu M, et al. Biol Reprod
2011;84:680–97 (31). Bottom panel, reprinted from Xu M et al.
Hum Reprod 2009;24:2531–40 (29) by permission of the authors
and Oxford University Press.
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undergo maturation (66). IVG oocytes may require a further
period of growth within the cumulus complex before matu-
ration (22). One way to achieve this ﬁnal growth phase of the
oocyte is removal of the oocyte–cumulus cell unit from the
antral follicle. Maintaining oocyte–somatic cell interactions
and cytoskeleton stability is important at this stage, and in
cow follicles it has been demonstrated that the correct bal-
ance of activin and FSH in vitro affects these processes (22).
Oocyte growth within human complexes has been dem-
onstrated in vitro (33), and live births have been reported
with the use of cow oocyte–granulosa cell complexes that
were aspirated from immature follicles and grown for 14
days until the oocyte was large enough to be matured
in vitro (70). Compact cumulus-oocyte complexes isolated
from IVG baboon antral follicles underwent IVM to yield oo-
cytes that reinitiated meiosis to the metaphase II stage, with
a normal appearing spindle structure (31). Fertilization was
not attempted in that study. These results give encourage-
ment that a similar system could be applied to human
cumulus-oocyte complexes aspirated from IVG follicles to
achieve oocyte diameters suitable to undergo IVM.
Alternatively, in vitro developed follicles that reach the
antral stage can also be treated with recombinant hCG in the
medium to examine reinitiation of meiotic maturation of the
oocyte within the follicle (27, 28, 63). Healthy and
degenerating oocytes are obtained from small antral stage
(0.5–1 mm diameter) IVG macaque follicles. The majority
of healthy oocytes (100 mm diameter) remain at the
germinal vesicle stage. However, metaphase II–stage
oocytes (>110 mm) within an expanded cumulus matrix
have been retrieved from hCG-treated macaque antral folli-
cles after growth from both primary and secondary follicles
under chemically deﬁned conditions. Fertilization can occur
after insemination by intracytoplasmic sperm injection, but
to date only the resulting zygotes from secondary follicle
culture cleave, and embryonic development is arrested
within 3 days in vitro. Thus, the few oocytes obtained
from IVG primary and secondary macaque follicles with
the use of the alginate encapsulated culture system can
achieve nuclear maturation and fertilization, but they do
not complete the cytoplasmic maturation necessary for em-
bryonic development.
Evidence of normal offspring derived from IVG of pri-
mordial (5, 6) and secondary follicles both with (11) and
without (7, 71) alginate in mice provides an impetus for
considering the feasibility of follicle culture to someday
achieve births in nonhuman primates, followed by clinical
translation to humans. A realistic concern remains whether
culture systems would confer interference at the epigenetic
level and perhaps alter imprinting patterns in oocytes and
the maintenance of genomic imprinting required for
subsequent normal embryonic development. Although only
a few investigations have been made to date, correct DNA
methylation establishment has been observed in mouse and
sheep oocytes derived from IVG follicles (72). Whether
normal imprinting establishment and maintenance would
be sustained in primate oocytes and embryos derived from
follicles grown in deﬁned culture conditions is currently
unknown.T
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Because only a small proportion of preantral follicles
reaching the antral state in vitro enclose fully grown oocytes
surrounded by cumulus cells, current culture systems favor
somatic cell function perhaps at the expense of the oocyte,
as they fall short of supporting oocyte-granulosa cell commu-
nication, leading to oocyte competence. Oocyte-derived fac-
tors, such as growth/differentiation factor 9 and bone
morphogenetic protein 15, secreted during their characteristic
stages of folliculogenesis would be logical biomarkers of oo-
cyte function to assess during in vitro follicle culture (20).
However, reagents for noninvasive assays of oocyte-speciﬁc
factors to evaluate oocyte function while enclosed in prean-
tral follicles during their growth and development in vitro
are not yet available for routine use. Furthermore, if oocytes
were healthy and functioning normally within the cultured
follicles, there should be no need to add exogenous oocyte-
speciﬁc factors; however, these experiments have not yet
been performed with primate follicles. Thus, manipulation
of current follicle culture systems (i.e., media components)
to optimize oocyte–somatic cell communication throughout
growth to the antral stage in vitro are limited to morphologic
measurements and hormone production of somatic cells, with
invasive removal of cumulus-oocyte complexes at the end of
culture to assess oocyte viability and competence.
CONCLUSION
Major hurdles remain for improving culture systems to pro-
mote coordinated development of the cumulus-oocyte com-
plex to achieve oocyte growth and the competence to
produce embryos, and to attain live offspring as the ultimate
clinical end point. Current yields of mature oocytes from IVG
follicles are low; therefore, a concomitant goal is to increase
the efﬁciency and reproducibility of producing mature com-
petent oocytes. This is no small task considering the complex
systems that regulate oocyte development and ultimate func-
tion (73). A looming challenge remains in evaluating the util-
ity of current culture systems to support the growth and
function of cryopreserved-thawed follicles for clinical use
in patients who have banked ovarian tissue. Early investiga-
tions are yielding promising results. The survival and growth
of preantral follicles from frozen-thawed human (51) and
vitriﬁed-thawed macaque (44, 74, 75) ovarian tissue has
been recently demonstrated. Continued growth of alginate-
encapsulated secondary follicles from vitriﬁed ovarian tissue
to the antral stage in macaques is accompanied by steroido-
genesis in vitro (44, 74, 75). Individually cryopreserved
macaque preantral follicles (76) and human follicles
enclosed in biomatrices before cryopreservation (53) can
also survive and grow in vitro after thawing.
Advances in bioengineering novel matrices that support
follicle survival, growth, somatic cell differentiation, and
germ cell maturation, as historically and elegantly demon-
strated in the mouse model, are critical for further progress
in human follicle culture. For example, biodegradable matri-
ces with interpenetrating networks (IPN) of ﬁbrin (77) can be
engineered to link proteins within the matrix allowing local
and sustained delivery of growth factors. Indeed, a novel
VEGF-containing IPN matrix supported folliculogenesis and
oocyte maturation, resulting in live offspring when trans-
planted to the ovarian bursa in mice (78). These new matrices
will allow studies of individual or combinations of growth
factors to improve folliculogenesis in vitro that supports the
coordinated development of somatic and germ cells necessary
for embryonic competence and production of live offspring.
Emerging design of hydrogels containing cross-linked pep-
tides that degrade in response to proteases secreted by the fol-
licle can locally allow follicle expansion while maintaining
the integrity of the hydrogel essential for supporting the 3D
architecture of the follicle in vitro that is essential for support-
ing oocyte growth and competence (79). In contrast to algi-
nate, which is not degradable, these synthetic hydrogel
systems with ‘‘tunable’’ properties allow the follicle to inﬂu-
ence its own local environment. These systems will enhance
the ability of human follicles to volumetrically expand be-
yond the 1-mm diameter currently achieved with the alginate
matrix to diameters (i.e., 5 mm in women) that represent those
capable of producing competent oocyte and live births
in vivo.
Technologies for human follicle culture today are compa-
rable to the early beginnings of human IVF. Consistent and
careful research in human and nonhuman primate models
will focus on optimizing culture conditions that favor efﬁ-
cient production of meiotically and developmentally compe-
tent oocytes from fresh or cryopreserved ovarian tissue that
can be performed in a clinical infertility setting (21). While
aiming toward the lofty goal of fertility preservation, the
amazing recent advancements in the culture of individual
or groups of primate follicles in vitro is also providing insights
into the basic biology of primate folliculogenesis that have
never before been possible. Whether these systems ever reach
clinical application or not, they are still invaluable for provid-
ing insight into the follicular system.
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